Nanobiotix S.A. (NBTX) reporting calendar
Nanobiotix S.A. files periodic reports with the SEC as NBTX on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 6
Open NBTX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001760854-26-000003 |
| 20-F | 31 Dec 2024 | 2 Apr 2025 | 92 days | 0001760854-25-000005 |
| 20-F | 31 Dec 2023 | 24 Apr 2024 | 115 days | 0001760854-24-000004 |
| 20-F | 31 Dec 2022 | 24 Apr 2023 | 114 days | 0001760854-23-000005 |
| 20-F | 31 Dec 2021 | 8 Apr 2022 | 98 days | 0001628280-22-008842 |
| 20-F | 31 Dec 2020 | 7 Apr 2021 | 97 days | 0001628280-21-006675 |
Source: SEC EDGAR company submissions for CIK 0001760854. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.